|
|
|
|
Prebiotic prevents the development of gastrointestinal motility disorders caused by omeprazole
L.M. Korinchak
Pavlo Tychyna Uman State Pedagogical University, Uman, Ukraine
DOI: https://doi.org/10.15407/fz69.05.083
Abstract
The synthetic disaccharide lactulose, consisting of fructose and galactose, after oral administration in
an unchanged form reaches the lower part of the gastrointestinal tract, where under the action of normal
flora it is broken down into short-chain fatty acids that stimulate colon motility. The effect of lactulose on
gastrointestinal tract motility in the conditions of its long-term suppression by omeprazole has not been
investigated. We studied the influence of lactulose on spontaneous and carbachol-stimulated gastric and
colonic motility in rats treated with omeprazole for 28 days. The animals were divided into 3 groups. The
first group of animals served as a control. The animals in the second group were administered omeprazole
intraperitoneally at a dose of 14 mg/kg orally once a day for 28 days. The animals in the third group were
simultaneously injected intraperitoneally with omeprazole and prebiotic lactulose at a dose of 0.2 g/kg
orally once a day for 28 days. On the day after the last injections of drugs, we investigated the spontaneous
and carbachol-stimulated contractions in the stomach and colon by the balloon graphic method. It was
found that the frequency of spontaneous and stimulated contractions in the stomach and colon did not
change significantly after 28 days of omeprazole treatment. The amplitude and index of spontaneous and
carbachol-stimulated contractions in the stomach and colon were significantly weaker compared to the
control. One day after the 28-day simultaneous administration of omeprazole and lactulose the amplitude
and index of spontaneous and stimulated contractions in the stomach and colon increased compared with
the group of rats treated with omeprazole alone. We concluded that the positive effect of lactulose on gastric
and colon motility is a result of the prebiotic properties of lactulose which leads to the normalization of the
microbiocenosis in the gastrointestinal tract and the elimination of the inflammatory process in it.
Keywords:
stomach; colon; spontaneous and stimulated contractions; carbachol; omeprazole; lactulose.
References
- Aziz I, Whitehead WE, Palsson OS, Tömblom H, Simrén M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol. 2020 Jan;14(1):39-46.
CrossRef
PubMed
- Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020 Apr;158(5):1232-49.
CrossRef
PubMed PubMedCentral
- Milosavljevic T, Popovic DD, Mijac DD, Milovanovic T, Krstic S, Krstic M. Chronic constipation: Gastroenterohepatologist's approach. Dig Dis. 2022;40(2):175-80.
CrossRef
PubMed
- Forootan M, Bagheri N, Darvishi M. Chronic constipation: A review of literature. Medicine (Baltimore). 2018 May;97(20):e10631.
CrossRef
PubMed PubMedCentral
- Pilipenko S, Kabanov O. Motor activities of the rat stomach after long-term injection of omeprazole and omeprazole with multiprobiotic "Apibact". Bull Taras Shevchenko Natl Univ Kyiv. Biology. 2013;3(65):100-101.
- Pilipenko SV, Beregova TV, Kabanov OV, Yankovskyi DS. The influence of multiprobiotic "Apibact" on colon motility in conditions of long-ter hypoacidity. Bull Probl Biol Med. 2014;106(1):162-6.
- Wilkins T, Sequoia J. Probiotics for gastrointestinal conditions: A summary of the evidence. Am Fam Phisician. 2017 Aug1;96(3):170-8.
- Domingo JJS. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterol Hepatol. 2017 Jun-Jul;40(6):417-29.
CrossRef
- Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect. 2018 Feb;76(2):111-20.
CrossRef
PubMed
- Wen H, Yin X, Yuan Z, Wang X, Su S. Comparative Analysis of Gut Microbial Communities in Children under 5 Years Old with Diarrhea. J Microbiol Biotechnol. 2018 Apr 28;28(4):652-62.
CrossRef
PubMed
- Men X, Zhang G, Cao H, Yu D, Fang X, de Vos WM, Wu H. Gut Dysbacteriosis and intestinal disease: mechanism and treatment. J Appl Microbiol. 2020 Oct;129(4):787-805.
CrossRef
PubMed
- Bamigbade GB, Subhash AJ, Kamal-Eldin A, Nystrom L, Ayyash M. An updated review on prebiotics: Insights on potentials of food seeds waste as source of potentials prebiotics. Molecules. 2022 Sep;27(18):5947.
CrossRef
PubMed PubMedCentral
- Hiraishi K, Zhao F, Kurahara L-H, Li X, Yamashita T, Hashimoto T, et al. Lactulose Modulates the Structure of Gut Microbiota and Alleviates Colitis- Associated Tumorigenesis. Nutrients. 2022 Feb;14(3):649.
CrossRef
PubMed PubMedCentral
- Sueyoshi M, Fukunaga M, Mei M, Nakajima A, Tanaka G, Murase T, et al. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clin. Exp. Nephrol. 2019;23:908-19.
CrossRef
PubMed PubMedCentral
- Zádori ZS, Fehér A, Al-Khrasani. Imidazoline versus alpha2-adrenoreceptors in the control of gastric motility in mice. Eur J Pharmacol. 2013;705(1-3):61-7.
CrossRef
PubMed
Bernik OO, Vakal SYe, Dvorschenko KO, Zub O, Ostapchenko LI. Biochemical indicators of the functional state of the liver of rats under conditions of prolonged hypoacidity. Exp Slin Physiol Biochem. 2011;4(56):7-
- [Ukrainian].
- Dvorschenko K, Torgalo Ye, Khilko T, Tomachynska L, Stepanov Yu, Yakubtsova I, Ostapchenko L. Research of biochemical mechanisms of rat liver functioning under conditions of long-term hypoacidity and development of methods for their correction. Problems of regulation of physiological functions. Kyiv Univ Publ Print Center. 2012;15;17-22. [Ukrainian].
- Kuo C-J, Lin C-Y, Chen C-W, Hsu C-Y, Hsieh S-Y, Chiu C-T, Lin W-R. Risk of enteric infection in patients with gastric acid suppressive drugs: A population-based casecontrol study. J Pers Med. 2021 Oct;11(11):1063.
CrossRef
PubMed PubMedCentral
- Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, et al. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006;55:476-80.
CrossRef
PubMed
- Wotzka SY, Kreuzer M, Maier L, Zund M, Schlumberger M, Nguyen B, et al. Microbiota stability in healthy individuals after single-dose lactulose challenge - A randomized controlled study. PLoS One. 2018 Oct;13(10):e0206214.
CrossRef
PubMed PubMedCentral
- Zhang X, Zheng J, Jiang N, Sun G, Bao X, et al. Modulation of gut microbiota and intestinal metabolites by lactulose improves loperamide-induced constipation in mice. Eur J Pharm Sci. 2021 Mar; 158:105676.
CrossRef
PubMed
|
|
|
|
|
|
|